Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENALEPSIE
2014-003003-30Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naloxone in sudden unexpected death in epilepsy (SUDEP), epilepsy, sponsored by Hospices Civils de Lyon. Started Jun 2015; status: completed.
02
Drugs
naloxone
03
Conditions
sudden unexpected death in epilepsy (SUDEP)epilepsy
Beyond the preview
Go deeper on 2014-003003-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003003-30.